Deprivation and prognosis in patients with Pulmonary Arterial Hypertension: missing the effect of deprivation on a rare disease?

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Sofianopoulou has nothing to disclose.

Conflict of interest: Dr. Church has nothing to disclose.

Conflict of interest: Dr. Coghlan reports grants and personal fees from Johnson & Johnson, personal fees from Glaxo Smith Klein, personal fees from Bayer, personal fees from MSD, outside the submitted work.

Conflict of interest: Dr. Howard has nothing to disclose.

Conflict of interest: Dr. Johnson reports grants and personal fees from Actelion, grants and personal fees from MSD, outside the submitted work.

Conflict of interest: Dr. Kiely has nothing to disclose.

Conflict of interest: Dr. Lawrie reports grants from British Heart Foundataion, grants from Medical Research Council, grants, personal fees and other from Actelion Pharmaceuticals Ltd, grants and personal fees from GlaxoSmithKline, outside the submitted work.

Conflict of interest: Dr. Lordan has nothing to disclose.

Conflict of interest: Dr. Wilkins has nothing to disclose.

Conflict of interest: Dr. Wort has nothing to disclose.

Conflict of interest: Dr. Morrell has nothing to disclose.

Conflict of interest: Dr. Toshner reports personal fees from GSK, grants and personal fees from J&J/Actelion, grants from Merck, grants from Bayer, outside the submitted work.